INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2024) Q3 2024 |
(Jun 30 2024) Q2 2024 |
(Dec 31 2023) Q4 2023 |
(Sep 30 2023) Q3 2023 |
(Jun 30 2023) Q2 2023 |
Revenue From Contract With Customer Excluding Assessed Tax |
- |
- |
|
- |
- |
Fair Value Adjustment Of Warrants |
- |
- |
|
-0.13 |
0.10 |
Other Revenue |
- |
- |
|
- |
1.01 |
Total Revenue |
0.13 |
0.81 |
1.51 |
1.26 |
1.11 |
Cost of Goods and Services Sold |
0.34 |
0.16 |
12.44 |
2.46 |
1.91 |
Gross
Profit |
-0.21 |
0.65 |
-10.94 |
-1.19 |
-0.79 |
Selling, Administration, Marketing |
3.14 |
6.37 |
-6.73 |
8.92 |
8.33 |
Depriciation & Amortization |
0.00 |
0.00 |
-0.12 |
0.12 |
0.19 |
Research and Development Expense |
0.41 |
3.59 |
-3.96 |
2.13 |
2.88 |
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) |
- |
- |
-13.47 |
- |
- |
Other operatinig exp. /-income |
4.17 |
-0.68 |
-9.64 |
-0.70 |
9.09 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
8.06 |
9.44 |
27.08 |
12.92 |
22.40 |
Operating income/-loss
|
-7.93 |
-8.63 |
-25.70 |
-11.66 |
-21.29 |
Other Deductions / - Income |
Interest expense |
0.01 |
0.05 |
0.04 |
- |
0.01 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
0.01 |
-0.05 |
0.04 |
- |
0.01 |
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net |
- |
- |
- |
- |
- |
Foreign Currency Transaction Gain (Loss), before Tax |
1.67 |
-0.16 |
-0.01 |
-0.01 |
0.16 |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
0.00 |
2.71 |
0.13 |
0.28 |
0.37 |
Loss Contingency |
- |
0.04 |
- |
- |
- |
Total costs & expenses |
9.74 |
12.08 |
27.24 |
13.19 |
22.94 |
Income /-loss before income taxes |
-9.62 |
-11.27 |
-25.73 |
-11.93 |
-21.83 |
Income taxes expenses/-benefit |
- |
- |
0.00 |
-0.08 |
0.00 |
Income after income taxes |
-9.62 |
-11.27 |
-25.73 |
-11.85 |
-21.83 |
Net income/-loss
of other equity |
0.00 |
- |
- |
- |
0.00 |
Income/-loss
from cont. Ops. |
-9.62 |
-11.27 |
-25.73 |
-11.85 |
-21.83 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
-8.91 |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-18.52 |
-11.27 |
-25.73 |
-11.85 |
-21.83 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-18.52 |
-11.27 |
-25.73 |
-11.85 |
-21.83 |
EBIT |
-9.60 |
-11.33 |
-25.69 |
-11.93 |
-21.82 |
EBITD |
-9.56 |
-11.33 |
-22.68 |
-11.93 |
-21.82 |
EBITDA |
-9.56 |
-11.33 |
-22.04 |
-11.93 |
-21.82 |